Introduction
The first half of 2019 has witnessed a lot of activity in the
pharma space, so much so that the e-pharmacy saga – a
pressing development towards the close of 2018 - has taken a
temporary backseat this year. Instead, the new stars of 2019 so far
have been price regulation and regulation of electronic nicotine
delivery systems. 2019 also saw a significant piece of legislation
introduced - the New Drugs and Clinical Trial Rules, 2019 - which
has already begun making waves in the industry.
Some of the major developments that have taken place so far are
captured below:
Indian Government Notifies New Clinical Trial Regime
The Ministry of Health and Family Welfare ("Health
Ministry") has notified the New Drugs and Clinical
Trials Rules, 2019 ("New Drugs & CT
Rules") to replace the existing regulatory framework
governing clinical trials in India under the Drugs and Cosmetics
Rules, 1945 ("D&C
Rules").1 The New Drugs & CT Rules are
more comprehensive and